Responsible Genetic Data Handling Disclosure for Biotech Companies

As genetic research advances and biotech firms handle increasingly sensitive genomic information, transparent reporting on data handling practices has become a cornerstone of strong ESG performance. This Responsible Genetic Data Handling Disclosure template helps biotech companies demonstrate their commitment to ethical research, robust data security, and proper consent management.

Why genetic data governance matters for ESG reporting

Genetic data is among the most sensitive information a company can hold—it's permanent, uniquely identifying, and can reveal information about family members and future health risks. Stakeholders including investors, regulators, research partners, and the public expect biotech firms to go beyond basic compliance and show leadership in responsible data stewardship.

This form enables your organization to clearly document:

• Consent management protocols that respect participant autonomy and cultural considerations
• Data security measures protecting genomic information throughout its lifecycle
• Research ethics oversight structures ensuring independent review and accountability
• Transparency commitments around data usage, sharing, and commercialization
• Incident response procedures and breach notification protocols

Built for biotech compliance and stakeholder confidence

Whether you're preparing annual ESG disclosures, responding to investor due diligence, supporting grant applications, or demonstrating best practices to research partners, this template structures your reporting in a clear, comprehensive format. The form captures both policy-level commitments and operational details, giving stakeholders confidence that your genetic data handling meets the highest ethical standards.

Paperform's calculation and conditional logic features let you tailor sections based on your company's specific research activities, while built-in validation ensures complete, accurate submissions. Once completed, you can export reports to PDF, integrate responses with your ESG reporting stack via Stepper workflows, or collect eSignatures from responsible executives using Papersign to formalize accountability.

Designed for biotech, research institutions, and genomic data stewards

This template is ideal for:

• Biotech and pharmaceutical companies conducting genetic research or offering genomic testing
• Research institutions handling genetic data as part of clinical trials or population studies
• Genetic testing companies providing direct-to-consumer or clinical genomic services
• ESG and compliance teams responsible for transparent reporting on data ethics

Paperform is trusted by over 500K teams worldwide, is SOC 2 Type II and GDPR compliant, and provides the security and flexibility biotech firms need for sensitive ESG reporting. Demonstrate your commitment to responsible genetic data handling with a disclosure framework that meets stakeholder expectations and supports your broader ESG strategy.